Eli Lilly Disputes New York Times Report
Eli Lilly & Co. downplayed the risks of its schizophrenia and bipolar disorder drug Zyprexa while also encouraging doctors to prescribe the drug for patients that had neither condition, according to...To view the full article, register now.
Already a subscriber? Click here to view full article